Novel molecular mechanisms for Prph2‐associated pattern dystrophy
Open Access
- 29 November 2019
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 34 (1) , 1211-1230
Abstract
Mutations in peripherin 2 ( PRPH2 ) have been associated with retinitis pigmentosa (RP) and macular/pattern dystrophies, but the origin of this phenotypic variability is unclear. The majority of Prph2 mutations are located in the large intradiscal loop (D2), a region that contains seven cysteines involved in intra‐ and intermolecular disulfide bonding and protein folding. A mutation at cysteine 213, which is engaged in an intramolecular disulfide bond, leads to butterfly‐shaped pattern dystrophy in humans, in sharp contrast to mutations in the adjacent cysteine at position 214 which result in RP. To help understand this unexpected phenotypic variability, we generated a knockin mouse line carrying the C213Y disease mutation. The mutant Prph2 protein lost the ability to oligomerize with rod outer segment membrane protein 1 (Rom1), but retained the ability to form homotetramers. C213Y heterozygotes had significantly decreased overall Prph2 levels as well as decreased rod and cone function. Critically, supplementation with extra wild‐type Prph2 protein elicited improvements in Prph2 protein levels and rod outer segment structure, but not functional rescue in rods or cones. These findings suggest that not all interruptions of D2 loop intramolecular disulfide bonding lead to haploinsufficiency‐related RP, but rather that more subtle changes can lead to mutant proteins stable enough to exert gain‐of‐function defects in rods and cones. This outcome highlights the difficulty in targeting Prph2‐associated gain‐of‐function disease and suggests that elimination of the mutant protein will be a pre‐requisite for any curative therapeutic strategy.Keywords
This publication has 62 references indexed in Scilit:
- Prominin-1 Is a Novel Regulator of Autophagy in the Human Retinal Pigment EpitheliumInvestigative Ophthalmology & Visual Science, 2017
- High Prevalence of PRPH2 in Autosomal Dominant Retinitis Pigmentosa in France and Characterization of Biochemical and Clinical FeaturesAmerican Journal of Ophthalmology, 2015
- Gene Therapy for PRPH2-Associated Ocular Disease: Challenges and ProspectsCold Spring Harbor Perspectives in Medicine, 2014
- ABCA4andROM1:Implications for Modification of thePRPH2-Associated Macular Dystrophy PhenotypeInvestigative Ophthalmology & Visual Science, 2010
- A Partial Structural and Functional Rescue of a Retinitis Pigmentosa Model with Compacted DNA NanoparticlesPLOS ONE, 2009
- Genetic Supplementation of RDS Alleviates a Loss-of-function Phenotype in C214S Model of Retinitis Pigmentosa2008
- Novel human pathological mutations. Gene symbol: RDS. Disease: macular dystrophy.2007
- Analysis of the rds/peripherin·rom1 Complex in Transgenic Photoreceptors That Express a Chimeric ProteinJournal of Biological Chemistry, 1999
- The Effect of Peripherin/rds Haploinsufficiency on Rod and Cone PhotoreceptorsJournal of Neuroscience, 1997
- Defective subunit assembly underlies a digenic form of retinitis pigmentosa linked to mutations in peripherin/rds and rom-1Proceedings of the National Academy of Sciences, 1996